Continued treatment with GLP-1 RAs plateaued at 22.5% with tirzepatide and 9.714.9% with semaglutide after 1718 months
The primary metabolic defects are insulin resistance (the bodys cells do not respond well to insulin) and relative insulin deficiency (the pancreas cannot keep up with insulin demand)
Other side effects of GLP-1 use: Dizziness Fatigue Gastrointestinal issues (diarrhea, constipation, gas) Headaches Stomach issues (nausea, vomiting, pain or bloating) Heart palpitations Chest pain Harvard Medical School cited another common issue with the rapid weight loss drug: the side effect coined Ozempic face, where the skin on the face sags with additional wrinkles
Our team handles the intricate prior authorization process, liaising directly with your insurer to streamline clinical documentation submissions
The oral tablet is marketed as liposomal, which has no peer-reviewed bioavailability data on it
Effective options span lifestyle (exercise, weight management, anti-inflammatory diet), medications (NSAIDs, sometimes hormone therapy), and addressing reversible compounders